Next Article in Journal
Book Review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty
Previous Article in Journal
Patient with Inoperable Pheochromocytoma
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy

Grand River Regional Cancer Centre, 835 King Street West, Kitchener, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(3), 220-221; https://doi.org/10.3747/co.22.2400
Submission received: 3 March 2015 / Revised: 6 April 2015 / Accepted: 10 May 2015 / Published: 1 June 2015

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The guideline article “Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations” in this journal for the management of hypersensitivity reactions (HSR) to this group of chemotherapy agents is useful in clinical practice [...]

Share and Cite

MDPI and ACS Style

Bahl, M.; Dean, T. An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Curr. Oncol. 2015, 22, 220-221. https://doi.org/10.3747/co.22.2400

AMA Style

Bahl M, Dean T. An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Current Oncology. 2015; 22(3):220-221. https://doi.org/10.3747/co.22.2400

Chicago/Turabian Style

Bahl, Mala, and Terry Dean. 2015. "An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy" Current Oncology 22, no. 3: 220-221. https://doi.org/10.3747/co.22.2400

APA Style

Bahl, M., & Dean, T. (2015). An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Current Oncology, 22(3), 220-221. https://doi.org/10.3747/co.22.2400

Article Metrics

Back to TopTop